Literature DB >> 12856147

Graves' disease associated with anticardiolipin antibody positivity and acquired protein S deficiency.

Tomohiro Nakayama1, Tatsuo Yamamoto, Katsuo Kanmatsuse, Shinichiro Kokubun.   

Abstract

A 33-year-old woman had experienced recurrent pregnancy loss. She had positive anticardiolipin antibody and protein S deficiency. Her pregnancy was managed with anticoagulant therapy and she delivered a healthy infant. Three years after delivery, she reported progressive sweating, tremor, tachycardia, and a 4-kg weight loss. She was diagnosed with Graves' disease. This is a rare case of combined anticardiolipin antibody positivity, acquired protein S deficiency, and Graves' disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12856147     DOI： 10.1007/s00296-003-0291-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  17 in total

1.  Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.

Authors:  L M Maciel; S S Rodrigues; R S Dibbern; P A Navarro; E A Donadi
Journal:  Thyroid       Date:  2001-01       Impact factor: 6.568

2.  Anticardiolipin antibodies in Grave's disease: relationship with thrombin activity in vivo.

Authors:  F Marongiu; M Conti; M L Murtas; G G Sorano; G Mameli; G Salis; A Mathieu; E Martino
Journal:  Thromb Res       Date:  1991-12-15       Impact factor: 3.944

3.  Graves' disease associated with the primary antiphospholipid syndrome.

Authors:  L C Hofbauer; C Spitzweg; A E Heufelder
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

4.  Herbal medicines, Sairei-to and Tokishakuyaku-san, differently modulate the release of cytokines from decidual versus peripheral blood mononuclear cells.

Authors:  O Fujii; T Kanai; S Kouzuma; K Baba; A Miki; H Hyodo; T Yamashita; N Unno; Y Taketani
Journal:  Am J Reprod Immunol       Date:  2001-11       Impact factor: 3.886

5.  HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups.

Authors:  J P Ioannidis; M G Tektonidou; P G Vlachoyiannopoulos; C Stavropoulos-Giokas; M Spyropoulou-Vlachou; J D Reveille; F C Arnett; H M Moutsopoulos
Journal:  Hum Immunol       Date:  1999-12       Impact factor: 2.850

6.  [Antiphospholipid antibodies in Basedow disease].

Authors:  H Mayaudon; P Crozes; J P Riveline; B Boyer; P Simon; B Bauduceau
Journal:  Presse Med       Date:  1994-10-22       Impact factor: 1.228

7.  Enhancement of protein S anticoagulant function by beta2-glycoprotein I, a major target antigen of antiphospholipid antibodies: beta2-glycoprotein I interferes with binding of protein S to its plasma inhibitor, C4b-binding protein.

Authors:  J T Merrill; H W Zhang; C Shen; B T Butman; E P Jeffries; R G Lahita; B L Myones
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

8.  Protein S deficiency and pregnancy: is there a case for ylaxis?

Authors:  D M Paternoster; P Simioni; A Girolami
Journal:  Minerva Ginecol       Date:  1997-10

9.  Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.

Authors:  M Tonacchera; S Costagliola; F Cetani; J Ducobu; P Stordeur; G Vassart; M Ludgate
Journal:  Eur J Endocrinol       Date:  1996-01       Impact factor: 6.664

10.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Authors:  E Matsuura; Y Igarashi; T Yasuda; D A Triplett; T Koike
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.